Cairo - Alameda Healthcare, a leading Egyptian private healthcare group, announced today at a press conference its expansion plans for 2021. The plans will see the group expand its capacity and geographical presence, and forms part of its ongoing strategy to enhance the local healthcare market and offer best-in-class services to Egyptians.

During the conference, Alameda Chairman and Owner Dr. Fahad Khater elaborated on the group’s expansion strategy, which includes the addition of 100 beds at As-Salam International Hospital in Maadi as well as the inauguration of the group’s fourth facility, As-Salam International Hospital, New Cairo with a total capacity of 150 beds, aimed to start operations in the coming few weeks.

Following the inauguration of the new ASSIH New Cairo, Alameda will have a combined capacity of more than 1,000 beds, more than 128 outpatient clinics, as well as diagnostic and specialist centers, pharmacies, and a rehabilitation center.

Over the course of the past decade, Alameda has invested more than EGP 5 billion into its existing facilities, which includes As-Salam International Hospital – ASSIH at Maadi. ASSIH New Cairo; Dar Al Fouad Nasr City, and Dar Al Fouad 6th of October City, in addition to the Centers of Excellence, which provide integrated medical services in several specialties, and the “Tabibi” platform, which is specialized in providing health and home care services.

Alameda Healthcare is looking to pursue new expansion opportunities in both Cairo and the nation at large. The group is finalizing agreements, which will lead to investing a total of EGP 5 billion to launch facilities under the Alameda brand in the New Administrative Capital, Al Alamein, Alexandria, Assiut, and Mansoura. The group’s investments will have multiplier effects that enhance inclusive economic growth via the creation of decent jobs that will exceed 5,000 job opportunities. Moreover, Alameda will launch a nursing academy to further enhance its capacities and ensure that it is able to provide leading care to its patients.

The group further iterated its commitment towards establishing world-class centers of excellence (COEs) across its facilities. The COEs will be created in seven key specialties including cardiac sciences; neurosciences; oncology; orthopedics and spine; renal sciences and kidney transplants; GIT, liver disease and liver transplants; and respiratory diseases.

“At Alameda, we strive to offer innovative, state-of-the-art healthcare services, in line with global standards,” said Fahad Khater, Chairman  & Owner of Alameda Healthcare. “Our expansion strategy is central to our growth and will see us build on our existing capabilities and deliver on our founder’s vision to offer Egyptians premium healthcare services right here at home.”

“We seek to offer our patients leading care at all of our facilities and ensure that it is accessible to all,” said Alameda Healthcare CEO, Neeraj Mishra. “Digitalization and technology are therefore prioritized with our facilities constantly being upgraded with high-tech equipment u in order to offer our patients the very best level of care.”

Alameda installed Siemens’ latest generation PET-CT and established an entirely new state-of-the-art chemotherapy unit at Dar Al Fouad, Nasr City. By the end of the year, the group expects to have installed the most advanced True Beam LINAC from Varian at As Salam Maadi with total investment of EGP 60mln. The new accelerator will deliver radiotherapy - to tumors across various parts of the body. Besides, the bi-plane cardiology catheterization labs and neurosurgery’s most advanced microscope and navigation system.

Central to Alameda’s duty of care is promoting the wellbeing of the entirety of our community, which led to establishing the Khater Foundation for Community Development. The foundation has poured a total of approximately EGP 200 million into various initiatives with the aim of building and improving the country’s underserved communities.

Some of the initiatives include supporting Al Kasr Alainy hospital where Khater Foundation donated a CT Machine, Lithotripsy Machine & Cath Lab Machine. In addition to offering continuous support by providing supplies to Al Kasr Alainy’s Urology Unit, and nursing manpower to the Internal Medicine Unit. Moreover, the group commissioned a Kidney Transplant Unit and Dialysis Unit and offered nursing manpower at Abu Reesh Children Hospital. Besides, installing the Varian LINAC in the National Cancer Institute and Elekta LINAC at Cairo University

As part of its commitment to alleviating the needs of Egypt’s most vulnerable communities, Khater Foundation has been supporting various non-profit organizations representing civil society, including NGOs and foundations to build effective and long-term partnerships and strengthen their capacity.

As for the community-focused initiatives, the group supported the citizens of Ash Sharqia Governorate through construction of cemented roofs, medical convoys, telemedicine clinics, and providing food supplies. During the holy month of Ramadan, Khater Foundation supports 18,000+ people every year.

With a solid track record spanning more than three decades of expertise in the medical sector and a patient-centric approach, Alameda Healthcare is well positioned to capitalize on new opportunities in the market which will see it bring comprehensive, world-class care to Egyptians through its facilities.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.